|
COPYRIGHT 2003 Adams Business Media
The first quarter of 2003 marked a significant turning point for the medical devices industry. Key product approvals from the FDA through the first three months of the year are expected to spark dramatic shifts in the delivery and efficacy of medical treatments, and spur sharp growth for the companies winning FDA approval.
Probably the most significant development this year is the anticipated approval of a drug-coated stent for the delivery of medication, says James Terwilliger, an analyst with Morgan Keegan in Memphis. The approval is expected to come at the end...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
